Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/1999
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038985A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999038969A1 PROTEIN HUMAINE β-TrCP
08/05/1999WO1999038967A2 Recombinant proteins derived from hgf and msp
08/05/1999WO1999038966A1 Wnt-10a
08/05/1999WO1999038964A2 Promoter regions of the mouse and human telomerase rna component genes
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038881A1 67 human secreted proteins
08/05/1999WO1999029718A3 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
08/05/1999WO1999027096B1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
08/05/1999WO1999025843A3 Human checkpoint kinase, hcds1, compositions and methods
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999024472A3 Glycosylated antibodies and antibody fragments having reactive ketone groups
08/05/1999WO1999023216A3 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/05/1999WO1999021999A3 Wnt-1 inducible genes
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999014322A3 Allelic variant of human stat3
08/05/1999WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
08/05/1999WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/05/1999CA2319129A1 67 human secreted proteins
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/04/1999EP0933423A1 Meltrins
08/04/1999EP0933083A1 Process for the purification of serum albumin
08/04/1999EP0933082A1 Methods of manipulation of cell differentiation
08/04/1999EP0932691A1 Dna-constructs comprising intergenic ribosomal dna and methods to produce proteins using these dna-constructs
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932684A2 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/04/1999EP0932680A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis
08/04/1999EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/04/1999EP0932675A2 Epidermal differentiation factor
08/04/1999EP0932674A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
08/04/1999EP0932672A1 Human sulfonylurea receptor surh
08/04/1999EP0932668A1 Two human cathepsin proteins
08/04/1999EP0932626A1 G protein-coupled receptor antagonists
08/04/1999EP0932625A1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use
08/04/1999EP0932622A1 Vitamin d response element binding protein
08/04/1999EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods
08/04/1999EP0567585B1 Hepatic growth factor receptor is the met proto-oncogene
08/04/1999EP0365657B1 Dna encoding androgen receptor protein
08/04/1999CN1225128A Anti-human MP52 monoclonal antibody
08/04/1999CN1225126A Method for the production of polypeptides
08/04/1999CN1224759A Production and application of human endothelial cell inhibin gene and its expression product
08/04/1999CN1224758A Production and application of human angiogenesis inhibin gene, carrier and strain containing the gene as well as the expression product
08/04/1999CN1224757A Method for producing phytase
08/04/1999CN1224726A Human erythropoietin gene: high level expression in stably transfected mammalian cells
08/04/1999CN1044479C Process for preparation of anti-thrombin polypeptides
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
08/03/1999US5932704 Antibodies for GM-CSF receptor and uses thereof
08/03/1999US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof.
08/03/1999US5932701 ribA
08/03/1999US5932700 Efficient antitumor agent; diagnostic tool for detection of uterine tumors
08/03/1999US5932699 Retinoid X receptor-interacting polypeptides
08/03/1999US5932540 Vascular endothelial growth factor 2
08/03/1999US5932477 This novel enzyme is particularly useful for screening candidate compounds for their ability to serve as potential anti-depressant, antiasthmatic or anti-inflammatory agents.
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932471 DNA encoding chimeric toxin
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932465 Phosphodiesterase 8A
08/03/1999US5932459 Artificial tissues, methods for the production and the use thereof
08/03/1999US5932449 Recombinant antibody, fab fragments with light and heavy chains that bind clostridium toxin; detection in air, food, water and biological warfare
08/03/1999US5932448 Bispecific antibody heterodimers
08/03/1999US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present
08/03/1999US5932442 Human regulatory molecules
08/03/1999US5932440 Mammalian ribonuclease inhibitors and use thereof
08/03/1999US5932439 Escherichia coli K-12 strains for production of recombinant proteins
08/03/1999US5932438 Preparation of thaumatin sweeteners
08/03/1999US5932424 Screening compounds for binding sensitivity to peptide transport proteins in culture
08/03/1999US5932415 Processes and agents for detecting listerias
08/03/1999US5932259 Basic peptide fraction is obtained by hydrolyzing the basic protein fraction with a protease. useful for treating or preventing bone diseases such as osteoporosis.
08/03/1999US5932219 Polypeptides
08/03/1999US5932210 Partial or total deletion of the adenoviral protein ix dna and having a gene encoding a foreign protein or a functional fragment or mutant thereof.
08/03/1999US5932209 Bacillus thuringiensis δ-endotoxin
08/03/1999CA2093335C Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and composition
08/03/1999CA1340689C Human b-cell differentiation factor and process of producing said factor
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999038008A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
07/29/1999WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor
07/29/1999WO1999037800A1 Antimicrobial compounds
07/29/1999WO1999037793A1 Process for making desired polypeptides in yeast
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications
07/29/1999WO1999037772A1 Il-18 receptors
07/29/1999WO1999037769A1 Orphan receptors
07/29/1999WO1999037767A1 Novel collectin
07/29/1999WO1999037765A1 Human vanilloid receptor homologues
07/29/1999WO1999037763A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
07/29/1999WO1999037762A1 Trek-1 like two pore potassium channel
07/29/1999WO1999037684A1 Antibodies to death receptor 4 (dr4) and uses thereof
07/29/1999WO1999037683A1 MONOCLONAL ANTIBODY ANTI αv-INTEGRIN AND ITS USE TO INHIBIT αvβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN
07/29/1999WO1999037682A2 Antibodies against human il-12
07/29/1999WO1999037679A1 Ligand receptors and uses therefor
07/29/1999WO1999037676A1 Recombinant human mannan-binding proteins and process for producing the same
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037673A2 Antifreeze protein
07/29/1999WO1999037665A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof